Myeloablative vs reduced intensity conditioning in haploidentical transplantation.
Study #: GS17-02
Study Status: Published
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Solomon SR, St. Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang M-J, Eapen M.
Blood Advances. 2019, Oct 08: 3(19): 3(19):2836-2844. doi: 10.1182/bloodadvances.2019000627. Epub 2019, Oct 03. PMCID:PMC6784523.
PMID: 31582392
Abstract